PATENT CLAIM ANALYSIS

Application Number: 15922676
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["435", "007100"]

Abstract:
Provided herein is technology relating to the biological process of protein ubiquitination and particularly, but not exclusively, to compositions and methods for studying protein ubiquitination and developing therapeutics to modulate protein ubiquitination.

Claim (Index 25):
The method of  claim 21  wherein the E3 ligase is a mutant E3 ligase.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 90.0
- Lexical Diversity: 1.34615
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14856251', '15436399', '11685122', '14268977', '15086719']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6138470704296352
- 35 USC 102 Novelty (BERT): 0.6755486164698608
- Combined Prediction Score: 0.6200172250336577
- Mean Citation Score: 452.16141000000016
- Max Citation Score: 820.1045
- Similarity Product: 627.2363642244637

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test